# LAMIVUDINE

NDC: 60505-3252
Generic name: lamivudine
Labeler / Manufacturer: Apotex Corp.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20111202

FDA application: ANDA091606

## Active ingredients

- LAMIVUDINE: 300 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"60505-3252"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=60505-3252
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=34c02bcc-d6ff-99d4-8e6a-4a91908adca8